<p id="p001">Abatacept (cytotoxic T-lymphocyte–associated antigen 4–immunoglobulin
fusion protein [CTLA-4–Ig]) is a costimulatory inhibitor that targets B7-1 (CD80). The present …

Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy
(DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating …

Chronic kidney disease (CKD) has emerged as a global public health burden. Taiwan has
the highest incidence and prevalence rates of end‐stage renal disease (ESRD) in the world. …

BACKGROUND: Depression is related to morbidity and mortality in patients with kidney
failure treated by dialysis, but its influence on patients with earlier stages of chronic kidney …

Results In all subjects, the mean uric acid level was 7.9±2.0 mg/dl. During a median 2.8-year
follow-up, there were 471 (14.3%) deaths, 545 (16.5%) cardiovascular events, 1080 (32.3%…

Background. Quality of life (QOL) may be associated with morbidity and survival in end-stage
renal disease (ESRD), and is considered to be an important outcome measure for patients …

Results Over a median follow-up period of 23.2 (12.6–26.4) months, 66 (13.8%) patients
reached all-cause mortality or cardiovascular morbidity. The adjusted hazard ratio of the …

Background. Glomerular filtration rate (GFR) and co-morbidity at dialysis initiation in relation
to mortality in end-stage renal disease is still controversial. We studied factors potentially …

Dyslipidemia is highly prevalent in patients with chronic kidney disease (CKD) and the
relationship between dyslipidemia with renal outcomes in patients with moderate to advanced …

Background Chronic kidney disease (CKD) and hepatitis C virus (HCV) infection are closely
linked and both increase patient mortality. The association of HCV and risk of developing …